PHOSPHO1 and diabetes mellitus: Ebselen, another PHOSPHO1 inhibitor (Roberts et al., 2007), could improve insulin sensitivity (Wang et al., 2014; Polianskyte-Prause et al., 2022) and ameliorate diabetes-associated atherosclerosis (Chew et al., 2010) in mice.